Inactive Instrument

News Muscle Pharm Corporation. OTC Bulletin Board

Equities

US6273351022

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

2023	Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	CI
2023	FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	18/10/23	CI
FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	09/10/23	CI
Motion for Asset Sale Approved for MusclePharm Corporation	03/10/23	CI
FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.	26/09/23	CI
Stalking Horse Agreement Filed by MusclePharm Corporation	08/09/23	CI
Musclepharm Corporation Announces Resignation of Paul Karr as Director	31/08/23	CI
Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	28/08/23	CI
First Amended Disclosure Statement Approved for MusclePharm Corporation	28/08/23	CI
Bidding Procedure Approved for MusclePharm Corporation	17/08/23	CI
Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer	19/07/23	CI
SEC Charges Former MusclePharm Executives with Accounting and Disclosure Fraud	28/06/23	AQ
First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation	19/06/23	CI
Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	26/05/23	CI
Motion for Asset Sale Filed by MusclePharm Corporation	12/05/23	CI
First Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	10/05/23	CI
MusclePharm Corporation has withdrawn its IPO in the amount of $10 million.	16/04/23	CI
First Motion for Exclusivity Period Extension Filed by MusclePharm Corporation	10/04/23	CI
DIP Financing Approved for MusclePharm Corporation	08/03/23	CI
Amended DIP Financing Approved for MusclePharm Corporation	23/01/23	CI
Interim DIP Financing Approved for MusclePharm Corporation	09/01/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Muscle Pharm Corporation. OTC Bulletin Board

Equities

US6273351022

Summary

Filters